CapStone Upgrades Protalix (PLX) to Strong Buy; Calls Taliglucerase Alfa News a Positive
Tweet Send to a Friend
CapStone has issued an intraday upgrade on shares of Protalix BioTherapeutics (AMEX: PLX) today following news that the company's NDA ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
